Relmada Therapeutics, Inc. (RLMD)
7.03
+0.69
(+10.88%)
USD |
NASDAQ |
May 19, 16:00
7.035
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics EPS Diluted (Quarterly) : -0.22 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | -0.0962 |
| AN2 Therapeutics, Inc. | -0.2944 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.05M |
| Total Expenses (Quarterly) | 19.05M |
| Enterprise Value | 503.42M |
| Earnings Yield | -15.82% |
| Normalized Earnings Yield | -15.81 |